242 related articles for article (PubMed ID: 34279177)
21. Association between the bladder wall thickness and urodynamic findings in patients with spinal cord injury.
Silva JA; Gonsalves Mde C; de Melo RT; Carrerette FB; Damião R
World J Urol; 2015 Jan; 33(1):131-5. PubMed ID: 24573904
[TBL] [Abstract][Full Text] [Related]
22. Supratrigonal cystectomy with Hautmann pouch as treatment for neurogenic bladder in spinal cord injury patients: long-term functional results.
Gobeaux N; Yates DR; Denys P; Even-Schneider A; Richard F; Chartier-Kastler E
Neurourol Urodyn; 2012 Jun; 31(5):672-6. PubMed ID: 22532256
[TBL] [Abstract][Full Text] [Related]
23. Long-term urodynamic follow-up after external sphincterotomy in patients with spinal cord injury.
Takahashi R; Kimoto Y; Eto M
Neurourol Urodyn; 2018 Nov; 37(8):2625-2631. PubMed ID: 29717510
[TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of trigonal BTX-A injections for children with neurological detrusor overactivity secondary to spinal cord injury.
Hui C
J Pediatr Surg; 2020 Dec; 55(12):2736-2739. PubMed ID: 32571538
[TBL] [Abstract][Full Text] [Related]
25. More Than 15 Years of Experience with Intradetrusor OnabotulinumtoxinA Injections for Treating Refractory Neurogenic Detrusor Overactivity: Lessons to Be Learned.
Leitner L; Guggenbühl-Roy S; Knüpfer SC; Walter M; Schneider MP; Tornic J; Sammer U; Mehnert U; Kessler TM
Eur Urol; 2016 Sep; 70(3):522-8. PubMed ID: 27106070
[TBL] [Abstract][Full Text] [Related]
26. Endoscopic treatment of vesicoureteral reflux with non-simultaneous involuntary detrusor contraction in chronic spinal cord injury patients with neurogenic detrusor overactivity.
Vírseda MC; Salinas JC; Bolufer E; Esteban MF
Urol Int; 2014; 93(4):399-402. PubMed ID: 24642572
[TBL] [Abstract][Full Text] [Related]
27. [Percutaneous radiofrequency sacral rhizotomy in the treatment of neurogenic detrusor overactivity in spinal cord injured patients].
Ferreira RS; Levi d'Ancona CA; Dantas-Filho VP; Rodrigues Netto N; Miyaoka R
Actas Urol Esp; 2011 Jun; 35(6):325-30. PubMed ID: 21477886
[TBL] [Abstract][Full Text] [Related]
28. Botulinum toxin A modulates afferent fibers in neurogenic detrusor overactivity.
Conte A; Giannantoni A; Proietti S; Giovannozzi S; Fabbrini G; Rossi A; Porena M; Berardelli A
Eur J Neurol; 2012 May; 19(5):725-32. PubMed ID: 22212295
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of fesoterodine fumarate (8 mg) in neurogenic detrusor overactivity due to spinal cord lesion or multiple sclerosis: A prospective study.
Konstantinidis C; Samarinas M; Tzitzika M; Kratiras Z; Panagiotakopoulos G; Giannitsas K; Athanasopoulos A
Neurourol Urodyn; 2021 Nov; 40(8):2026-2033. PubMed ID: 34498773
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic effects of detrusor botulinum toxin A injection on neurogenic detrusor overactivity in patients with different levels of spinal cord injury and types of detrusor sphincter dyssynergia.
Chen CY; Liao CH; Kuo HC
Spinal Cord; 2011 May; 49(5):659-64. PubMed ID: 21243000
[TBL] [Abstract][Full Text] [Related]
31. A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin.
Popat R; Apostolidis A; Kalsi V; Gonzales G; Fowler CJ; Dasgupta P
J Urol; 2005 Sep; 174(3):984-9. PubMed ID: 16094019
[TBL] [Abstract][Full Text] [Related]
32. Acute, severe traumatic spinal cord injury: improving urinary bladder function by optimizing spinal cord perfusion.
Hogg FRA; Kearney S; Solomon E; Gallagher MJ; Zoumprouli A; Papadopoulos MC; Saadoun S
J Neurosurg Spine; 2022 Jan; 36(1):145-152. PubMed ID: 34479207
[TBL] [Abstract][Full Text] [Related]
33. A comparison of urodynamic findings between patients with complete and incomplete traumatic spinal cord injuries.
Sarı İF; Köklü K; Özişler Z; Özel S
J Spinal Cord Med; 2020 Jul; 43(4):449-454. PubMed ID: 30540550
[No Abstract] [Full Text] [Related]
34. Clinical usefulness of ultrasound assessment of detrusor wall thickness in patients with neurogenic lower urinary tract dysfunction due to spinal cord injury: urodynamics made easy?
Pannek J; Bartel P; Göcking K; Frotzler A
World J Urol; 2013 Jun; 31(3):659-64. PubMed ID: 23073657
[TBL] [Abstract][Full Text] [Related]
35. Protocol for a phase II, open-label exploratory study investigating the efficacy of fesoterodine for treatment of adult patients with spinal cord injury suffering from neurogenic detrusor overactivity for amelioration of autonomic dysreflexia.
Walter M; Ramirez AL; Lee AH; Rapoport D; Kavanagh A; Krassioukov AV
BMJ Open; 2018 Nov; 8(11):e024084. PubMed ID: 30467135
[TBL] [Abstract][Full Text] [Related]
36. Urodynamic findings in young men with chronic lower urinary tract symptoms.
Karami H; Valipour R; Lotfi B; Mokhtarpour H; Razi A
Neurourol Urodyn; 2011 Nov; 30(8):1580-5. PubMed ID: 21780163
[TBL] [Abstract][Full Text] [Related]
37. Effects of M274773, a neurokinin-2 receptor antagonist, on bladder function in chronically spinalized rats.
Abdel-Karim AM; Barthlow HG; Bialecki RA; Elhilali MM
J Urol; 2005 Oct; 174(4 Pt 1):1488-92. PubMed ID: 16145477
[TBL] [Abstract][Full Text] [Related]
38. [Video-urodynamic studies on 1800 patients with neurogenic bladder].
JU YH; LIAO LM; LI D; FU G; LIANG WL; XIONG ZS; WU J; SHI WB; HAN CS
Zhonghua Wai Ke Za Zhi; 2008 Oct; 46(20):1525-8. PubMed ID: 19094643
[TBL] [Abstract][Full Text] [Related]
39. Protocol for a randomized clinical trial investigating early sacral nerve stimulation as an adjunct to standard neurogenic bladder management following acute spinal cord injury.
Redshaw JD; Lenherr SM; Elliott SP; Stoffel JT; Rosenbluth JP; Presson AP; Myers JB;
BMC Urol; 2018 Aug; 18(1):72. PubMed ID: 30157824
[TBL] [Abstract][Full Text] [Related]
40. Initial experience with the treatment of neurogenic detrusor overactivity with a new β-3 agonist (mirabegron) in patients with spinal cord injury.
Wöllner J; Pannek J
Spinal Cord; 2016 Jan; 54(1):78-82. PubMed ID: 26503222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
